Long-term Outcomes of Cytomegalovirus Retinitis in the Era of Modern Antiretroviral Therapy: Results from a United States Cohort

Studies of the Ocular Complications of AIDS Research Group

Research output: Contribution to journalArticle

Abstract

Purpose To describe the long-term outcomes of patients with cytomegalovirus (CMV) retinitis and AIDS in the modern era of combination antiretroviral therapy. Design Prospective, observational cohort study. Participants Patients with AIDS and CMV retinitis. Methods Immune recovery, defined as a CD4+ T-cell count >100 cells/μl for ≥3 months. Main Outcome Measures Mortality, visual impairment (visual acuity

Original languageEnglish (US)
Article number8570
Pages (from-to)1452-1463
Number of pages12
JournalOphthalmology
Volume122
Issue number7
DOIs
StatePublished - Jul 1 2015

Fingerprint

Cytomegalovirus Retinitis
Acquired Immunodeficiency Syndrome
Vision Disorders
CD4 Lymphocyte Count
Visual Acuity
Observational Studies
Cohort Studies
Outcome Assessment (Health Care)
T-Lymphocytes
Mortality
Therapeutics

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Long-term Outcomes of Cytomegalovirus Retinitis in the Era of Modern Antiretroviral Therapy : Results from a United States Cohort. / Studies of the Ocular Complications of AIDS Research Group.

In: Ophthalmology, Vol. 122, No. 7, 8570, 01.07.2015, p. 1452-1463.

Research output: Contribution to journalArticle

Studies of the Ocular Complications of AIDS Research Group. / Long-term Outcomes of Cytomegalovirus Retinitis in the Era of Modern Antiretroviral Therapy : Results from a United States Cohort. In: Ophthalmology. 2015 ; Vol. 122, No. 7. pp. 1452-1463.
@article{afcf16814ab54db8a0c2d37d647e85ef,
title = "Long-term Outcomes of Cytomegalovirus Retinitis in the Era of Modern Antiretroviral Therapy: Results from a United States Cohort",
abstract = "Purpose To describe the long-term outcomes of patients with cytomegalovirus (CMV) retinitis and AIDS in the modern era of combination antiretroviral therapy. Design Prospective, observational cohort study. Participants Patients with AIDS and CMV retinitis. Methods Immune recovery, defined as a CD4+ T-cell count >100 cells/μl for ≥3 months. Main Outcome Measures Mortality, visual impairment (visual acuity",
author = "{Studies of the Ocular Complications of AIDS Research Group} and Douglas Jabs and Alka Ahuja and {Van Natta}, {Mark L} and Lyon, {Alice T.} and Steven Yeh and Ronald Danis",
year = "2015",
month = "7",
day = "1",
doi = "10.1016/j.ophtha.2015.02.033",
language = "English (US)",
volume = "122",
pages = "1452--1463",
journal = "Ophthalmology",
issn = "0161-6420",
publisher = "Elsevier Inc.",
number = "7",

}

TY - JOUR

T1 - Long-term Outcomes of Cytomegalovirus Retinitis in the Era of Modern Antiretroviral Therapy

T2 - Results from a United States Cohort

AU - Studies of the Ocular Complications of AIDS Research Group

AU - Jabs, Douglas

AU - Ahuja, Alka

AU - Van Natta, Mark L

AU - Lyon, Alice T.

AU - Yeh, Steven

AU - Danis, Ronald

PY - 2015/7/1

Y1 - 2015/7/1

N2 - Purpose To describe the long-term outcomes of patients with cytomegalovirus (CMV) retinitis and AIDS in the modern era of combination antiretroviral therapy. Design Prospective, observational cohort study. Participants Patients with AIDS and CMV retinitis. Methods Immune recovery, defined as a CD4+ T-cell count >100 cells/μl for ≥3 months. Main Outcome Measures Mortality, visual impairment (visual acuity

AB - Purpose To describe the long-term outcomes of patients with cytomegalovirus (CMV) retinitis and AIDS in the modern era of combination antiretroviral therapy. Design Prospective, observational cohort study. Participants Patients with AIDS and CMV retinitis. Methods Immune recovery, defined as a CD4+ T-cell count >100 cells/μl for ≥3 months. Main Outcome Measures Mortality, visual impairment (visual acuity

UR - http://www.scopus.com/inward/record.url?scp=84937734399&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937734399&partnerID=8YFLogxK

U2 - 10.1016/j.ophtha.2015.02.033

DO - 10.1016/j.ophtha.2015.02.033

M3 - Article

C2 - 25892019

AN - SCOPUS:84937734399

VL - 122

SP - 1452

EP - 1463

JO - Ophthalmology

JF - Ophthalmology

SN - 0161-6420

IS - 7

M1 - 8570

ER -